Covid vaccine delivered using Vaxxas patch goes into clinical trials
Vaxxas, a Brisbane-based company attempting to replace the needle and syringe for vaccine deliveries, has announced the first in-human trials for a Covid-19 vaccine candidate using its delivery platform. In a statement on Wednesday, the medtech company said a Phase I clinical study had been initiated, conducted at the University of the Sunshine Coast’s Sippy…
Details